Pharmacological Progress of Mitophagy Regulation

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Mitochondria are vital for cellular processes; dysfunction is linked to numerous pathologies.
• Targeting mitochondrial quality control, specifically mitophagy, offers therapeutic potential.
• A lack of specific pharmacological tools to modulate mitophagy hinders research.

Purpose of the Study:

• To review recent advancements in mitophagy modulators.
• To highlight the need for selective compounds that do not disrupt mitochondrial homeostasis.
• To summarize the current status of molecules influencing mitophagy.

Main Methods:

• Literature review of recently reported mitophagy modulators.
• Analysis of existing chemical probes and their limitations (e.g., oligomycin, antimycin A, CCCP/FCCP).
• Focus on molecules enabling selective removal of damaged mitochondria.

Main Results:

• Current mitophagy inducers like oligomycin and CCCP/FCCP have limitations.
• These compounds can disrupt normal mitochondrial function and energy regulation.
• Ongoing efforts aim to identify selective mitophagy-inducing agents.

Conclusions:

• Developing selective mitophagy modulators is critical for advancing mitochondrial research.
• Such compounds could provide new therapeutic strategies for diseases involving mitochondrial dysfunction.
• Further research is needed to identify and validate novel mitophagy-targeting molecules.